Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6026 USD | +3.90% | +6.65% | +2.57% |
Mar. 25 | North American Morning Briefing : Tech in Focus on -2- | DJ |
Mar. 18 | North American Morning Briefing : Investors -2- | DJ |
Chart calendar VBI Vaccines Inc.
Upcoming events on VBI Vaccines Inc.
Past events on VBI Vaccines Inc.
2023-11-16 | Society for Neuro-Oncology Meeting |
2023-11-14 04:20 pm | Q3 2023 Earnings Release |
2023-08-14 08:00 am | Q2 2023 Earnings Release |
2023-06-23 11:00 am | Annual General Meeting |
2023-06-21 03:00 am | European Association for the Study of the Liver Congress - Abstract Number: 3788 |
2023-05-15 08:00 am | Q1 2023 Earnings Release |
2023-04-11 | Reverse Split: 1 of 30 |
2023-03-13 08:00 am | Q4 2022 Earnings Release |
2023-02-28 01:00 pm | Investor Meeting - Raymond James & Associates, Inc. |
2023-02-18 01:10 am | Conference of the Asian Pacific Association for the Study of the Liver |
2022-11-17 | Society for Neuro Oncology Meeting - Poster Number CTIM-14 |
2022-11-16 03:00 am | Jefferies London Healthcare Conference |
2022-11-15 03:20 pm | Guggenheim Immunology and Neurology Conference |
2022-11-10 08:00 am | Q3 2022 Earnings Release |
2022-10-18 09:00 am | H.C. Wainwright Hepatitis B Virus Conference |
2022-09-18 | International HBV Meeting |
2022-08-08 08:00 am | Interim 2022 Earnings Release |
2022-06-26 05:00 am | European Association for the Study of the Liver International Liver Congress - Abstract Number: 1416 |
2022-06-22 11:30 am | Annual General Meeting |
2022-06-08 01:30 pm | Jefferies Healthcare Conference |
Annual results
Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 3,36 3,25 3.1% | 2,22 2,64 -15.93% | 1,06 1,26 -15.94% | 0,63 0,80 -21.13% | 1,08 1,00 8.2% | 13,0 |
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | -60,4 -56,3 -7.38% | -52,4 -52,0 -0.74% | -43,6 -42,8 -1.94% | -68,0 -65,0 -4.68% | -81,8 -76,3 -7.23% | -69,7 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -63,6 -59,6 -6.71% | -54,8 -53,5 -2.47% | -46,2 -45,1 -2.41% | -69,8 -70,0 0.31% | -113 -93,3 -21.45% | -98,3 |
Net income Million USD | Released Forecast Spread | -63,6 -59,6 -6.71% | -54,8 -53,9 -1.62% | -46,2 -44,8 -3.17% | -69,8 -70,0 0.31% | -113 -93,3 -21.45% | -98,3 |
EPS USD | Released Forecast Spread | -29,1 -26,6 -9.4% | -13,8 -13,8 0% | -6,30 -6,06 -3.96% | -8,10 -8,20 1.22% | -13,2 -10,1 -31.34% | -6,59 |
Announcement Date | 25/02/19 | 05/03/20 | 02/03/21 | 07/03/22 | 13/03/23 | - |
Quarterly results
Fiscal Period | December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,11 0,26 -58.12% | 0,08 0,14 -41.02% | 0,13 0,09 45.38% | 0,35 0,70 -50.88% | 0,32 1,29 -75.48% | 0,29 0,56 -47.58% | 0,49 0,82 -40.64% | 0,72 0,93 -22.5% | 6,62 13,3 -50.01% | 5,36 | 6,58 | 6,83 | 3,15 | 3,28 |
EBIT Million USD | Released Forecast Spread | -15,0 -15,9 5.64% | -20,9 -17,8 -17.22% | -15,9 -19,7 19.15% | -22,9 -16,7 -37.49% | -21,6 -20,3 -6.04% | -21,4 -19,6 -9.6% | -19,5 -18,7 -4.19% | -17,0 -17,2 1.19% | -6,47 -1,78 -263.43% | -3,11 | -2,07 | -1,99 | -5,84 | -5,89 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -15,8 -16,5 4.22% | -18,8 -19,0 1.05% | -21,3 -20,8 -2.15% | -45,7 -17,4 -162.36% | -25,2 -21,0 -19.78% | -21,1 -21,8 3.07% | -27,8 -19,4 -42.74% | -44,6 -18,7 -139.22% | -20,4 -3,28 -522.91% | -4,59 | -3,55 | -3,48 | -7,33 | -7,32 |
Net income Million USD | Released Forecast Spread | -15,8 -16,5 4.22% | -18,8 -19,0 1.05% | -21,3 -20,8 -2.15% | -45,7 -17,4 -162.36% | -25,2 -21,0 -19.78% | -21,1 -21,8 3.07% | -27,8 -19,4 -42.74% | -44,6 -18,7 -139.22% | -21,3 -3,28 -549.18% | -4,59 | -3,55 | -3,48 | -7,33 | -7,32 |
EPS USD | Released Forecast Spread | -1,80 -1,95 7.69% | -2,10 -2,20 4.55% | -2,40 -2,40 0% | -5,40 -2,10 -157.14% | -3,00 -2,40 -25% | -2,40 -1,95 -23.08% | -3,22 -2,27 -42.16% | -5,05 -2,16 -133.8% | -1,01 -0,14 -621.43% | -0,22 | -0,17 | -0,16 | -0,23 | -0,23 |
Announcement Date | 08/11/21 | 07/03/22 | 09/05/22 | 08/08/22 | 10/11/22 | 13/03/23 | 15/05/23 | 14/08/23 | 14/11/23 | - | - | - | - | - |
Past sector events for VBI Vaccines Inc.
2024-03-28 04:28 pm | CENTESSA PHARMACEUTICALS PLC: Q4 2023 Earnings Release |
2024-03-28 04:05 pm | ARRIVENT BIOPHARMA, INC.: Q4 2023 Earnings Release |
2024-03-27 | SAB BIOTHERAPEUTICS, INC.: Q4 2023 Earnings Release (Projected) |
2024-03-27 | JOINN LABORATORIES(CHINA)CO.,LTD.: Q4 2023 Earnings Release |
2024-03-27 | HANGZHOU TIGERMED CONSULTING CO., LTD: Q4 2023 Earnings Release |
2024-03-27 | ALPHAMAB ONCOLOGY: Q4 2023 Earnings Release |
2024-03-26 | PHARMARON BEIJING CO., LTD.: Q4 2023 Earnings Release |
2024-03-26 04:05 pm | KYVERNA THERAPEUTICS, INC.: Q4 2023 Earnings Release |
2024-03-26 04:01 pm | KORRO BIO, INC.: Q4 2023 Earnings Release |
2024-03-26 06:00 am | GYRE THERAPEUTICS, INC.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock
- Equities
- Stock VBI Vaccines Inc. - Nasdaq
- Calendar VBI Vaccines Inc.